Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Achilles Tendon | 6 | 2019 | 14 | 2.290 |
Why?
|
| Tendons | 11 | 2019 | 221 | 1.790 |
Why?
|
| Tendinopathy | 4 | 2019 | 54 | 1.510 |
Why?
|
| Biomechanical Phenomena | 22 | 2019 | 643 | 1.120 |
Why?
|
| Wound Healing | 4 | 2015 | 159 | 1.000 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 20 | 0.950 |
Why?
|
| Cartilage, Articular | 5 | 2015 | 419 | 0.870 |
Why?
|
| ADAM Proteins | 3 | 2013 | 41 | 0.860 |
Why?
|
| Animals | 18 | 2019 | 3681 | 0.740 |
Why?
|
| Rotator Cuff | 6 | 2019 | 308 | 0.730 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2019 | 2 | 0.650 |
Why?
|
| Shoulder | 5 | 2015 | 188 | 0.640 |
Why?
|
| Bursitis | 1 | 2019 | 13 | 0.630 |
Why?
|
| Bursa, Synovial | 2 | 2018 | 10 | 0.610 |
Why?
|
| Hyaluronan Synthases | 1 | 2018 | 5 | 0.600 |
Why?
|
| Calcaneus | 1 | 2018 | 3 | 0.590 |
Why?
|
| Lactic Acid | 1 | 2018 | 8 | 0.590 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 10 | 0.590 |
Why?
|
| Glucose | 1 | 2018 | 55 | 0.580 |
Why?
|
| Tendon Injuries | 4 | 2015 | 205 | 0.560 |
Why?
|
| Aggrecans | 3 | 2013 | 54 | 0.550 |
Why?
|
| Bone Screws | 4 | 2013 | 142 | 0.530 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 3 | 2013 | 34 | 0.510 |
Why?
|
| Signal Transduction | 1 | 2018 | 455 | 0.490 |
Why?
|
| Capsaicin | 1 | 2015 | 9 | 0.480 |
Why?
|
| Chondrogenesis | 1 | 2015 | 32 | 0.470 |
Why?
|
| Suture Anchors | 7 | 2014 | 101 | 0.470 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2015 | 30 | 0.470 |
Why?
|
| Mice, Knockout | 4 | 2018 | 311 | 0.450 |
Why?
|
| Male | 30 | 2019 | 14887 | 0.450 |
Why?
|
| Shoulder Joint | 7 | 2019 | 657 | 0.400 |
Why?
|
| Tibia | 6 | 2014 | 246 | 0.400 |
Why?
|
| Osteotomy | 4 | 2019 | 172 | 0.390 |
Why?
|
| Mice | 5 | 2019 | 1449 | 0.380 |
Why?
|
| Exercise Therapy | 1 | 2012 | 91 | 0.370 |
Why?
|
| Stress, Mechanical | 6 | 2015 | 157 | 0.350 |
Why?
|
| ADAMTS5 Protein | 3 | 2018 | 21 | 0.340 |
Why?
|
| Knee Injuries | 2 | 2013 | 204 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 454 | 0.340 |
Why?
|
| Joint Instability | 4 | 2011 | 395 | 0.320 |
Why?
|
| Anterior Cruciate Ligament | 4 | 2013 | 183 | 0.320 |
Why?
|
| Weight-Bearing | 7 | 2013 | 157 | 0.320 |
Why?
|
| Suture Techniques | 6 | 2019 | 160 | 0.310 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 606 | 0.310 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2009 | 23 | 0.300 |
Why?
|
| Absorbable Implants | 1 | 2009 | 27 | 0.300 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 290 | 0.290 |
Why?
|
| Rabbits | 4 | 2015 | 180 | 0.280 |
Why?
|
| Female | 25 | 2019 | 15334 | 0.280 |
Why?
|
| Plastic Embedding | 1 | 2007 | 1 | 0.270 |
Why?
|
| Cadaver | 13 | 2014 | 375 | 0.270 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2019 | 46 | 0.260 |
Why?
|
| Stifle | 1 | 2006 | 10 | 0.250 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 3 | 2013 | 201 | 0.250 |
Why?
|
| Genetic Variation | 1 | 2006 | 97 | 0.250 |
Why?
|
| Random Allocation | 3 | 2018 | 123 | 0.250 |
Why?
|
| Models, Animal | 5 | 2015 | 111 | 0.240 |
Why?
|
| Collagen Type III | 2 | 2015 | 12 | 0.230 |
Why?
|
| Humans | 25 | 2019 | 27307 | 0.220 |
Why?
|
| Collagen Type I | 2 | 2015 | 20 | 0.220 |
Why?
|
| Arthroplasty | 3 | 2019 | 159 | 0.220 |
Why?
|
| Glenoid Cavity | 2 | 2014 | 38 | 0.210 |
Why?
|
| Proteoglycans | 2 | 2015 | 133 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 197 | 0.200 |
Why?
|
| Middle Aged | 18 | 2019 | 9068 | 0.200 |
Why?
|
| Allografts | 2 | 2013 | 216 | 0.190 |
Why?
|
| Muscle, Skeletal | 4 | 2013 | 383 | 0.190 |
Why?
|
| Patellar Ligament | 2 | 2013 | 43 | 0.190 |
Why?
|
| Humerus | 2 | 2013 | 107 | 0.180 |
Why?
|
| Transplantation, Homologous | 6 | 2013 | 279 | 0.180 |
Why?
|
| Arthroscopy | 7 | 2014 | 1105 | 0.170 |
Why?
|
| Acetabulum | 2 | 2013 | 228 | 0.170 |
Why?
|
| Collagen | 2 | 2018 | 86 | 0.170 |
Why?
|
| Injections | 1 | 2019 | 42 | 0.160 |
Why?
|
| Regeneration | 1 | 2019 | 18 | 0.160 |
Why?
|
| Tenodesis | 2 | 2013 | 174 | 0.160 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 183 | 0.160 |
Why?
|
| Small Leucine-Rich Proteoglycans | 1 | 2018 | 1 | 0.150 |
Why?
|
| Dermatan Sulfate | 1 | 2018 | 1 | 0.150 |
Why?
|
| Chondroitin Sulfates | 1 | 2018 | 6 | 0.150 |
Why?
|
| Aerobiosis | 1 | 2018 | 1 | 0.150 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 10 | 0.150 |
Why?
|
| Orthopedic Procedures | 3 | 2010 | 314 | 0.150 |
Why?
|
| Glycolysis | 1 | 2018 | 13 | 0.150 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 25 | 0.150 |
Why?
|
| Pressure | 2 | 2015 | 65 | 0.150 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 55 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 55 | 0.140 |
Why?
|
| Menisci, Tibial | 2 | 2011 | 173 | 0.140 |
Why?
|
| Cell Survival | 2 | 2015 | 121 | 0.140 |
Why?
|
| Gene Expression | 2 | 2016 | 201 | 0.130 |
Why?
|
| Gamma Rays | 2 | 2013 | 15 | 0.130 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 26 | 0.120 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 80 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2016 | 165 | 0.120 |
Why?
|
| Bone Transplantation | 2 | 2014 | 203 | 0.110 |
Why?
|
| Ilium | 1 | 2014 | 29 | 0.110 |
Why?
|
| Integrins | 1 | 2013 | 14 | 0.100 |
Why?
|
| Hyaline Cartilage | 1 | 2013 | 14 | 0.100 |
Why?
|
| Physical Conditioning, Animal | 1 | 2013 | 8 | 0.100 |
Why?
|
| Aged | 11 | 2014 | 9120 | 0.100 |
Why?
|
| Materials Testing | 1 | 2014 | 123 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 328 | 0.100 |
Why?
|
| Rotator Cuff Injuries | 3 | 2012 | 316 | 0.100 |
Why?
|
| Femur Neck | 1 | 2012 | 21 | 0.100 |
Why?
|
| Femur Head | 1 | 2012 | 69 | 0.100 |
Why?
|
| Rats | 3 | 2010 | 660 | 0.100 |
Why?
|
| Bupivacaine | 1 | 2012 | 45 | 0.090 |
Why?
|
| Fibril-Associated Collagens | 1 | 2011 | 1 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 26 | 0.090 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 79 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 316 | 0.090 |
Why?
|
| Osseointegration | 1 | 2012 | 67 | 0.090 |
Why?
|
| Organ Size | 1 | 2011 | 95 | 0.090 |
Why?
|
| Alpha-Globulins | 1 | 2011 | 1 | 0.090 |
Why?
|
| Horse Diseases | 1 | 2011 | 3 | 0.090 |
Why?
|
| Ligaments | 1 | 2011 | 14 | 0.090 |
Why?
|
| Connective Tissue Diseases | 1 | 2011 | 9 | 0.090 |
Why?
|
| Bone Matrix | 1 | 2010 | 19 | 0.090 |
Why?
|
| Bone Remodeling | 1 | 2010 | 50 | 0.080 |
Why?
|
| Fatigue | 1 | 2010 | 60 | 0.080 |
Why?
|
| Upper Extremity | 1 | 2010 | 64 | 0.080 |
Why?
|
| Adult | 8 | 2014 | 7945 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 667 | 0.080 |
Why?
|
| Asepsis | 1 | 2008 | 2 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 1444 | 0.080 |
Why?
|
| Graft Survival | 1 | 2008 | 97 | 0.070 |
Why?
|
| Bone Nails | 1 | 2007 | 13 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 87 | 0.070 |
Why?
|
| Acrylic Resins | 1 | 2007 | 3 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 31 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2006 | 34 | 0.060 |
Why?
|
| Hip Joint | 1 | 2012 | 555 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 344 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2005 | 23 | 0.060 |
Why?
|
| Phenotype | 1 | 2006 | 313 | 0.060 |
Why?
|
| Knee Joint | 1 | 2011 | 760 | 0.060 |
Why?
|
| Femur | 1 | 2007 | 375 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 169 | 0.050 |
Why?
|
| Equipment Design | 2 | 2013 | 136 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 720 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 4841 | 0.040 |
Why?
|
| Young Adult | 2 | 2014 | 2032 | 0.040 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2016 | 3 | 0.030 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 3 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 20 | 0.030 |
Why?
|
| Prosthesis Failure | 2 | 2010 | 520 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 24 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 55 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 103 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 98 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 276 | 0.030 |
Why?
|
| Humeral Head | 1 | 2014 | 37 | 0.030 |
Why?
|
| Rotation | 1 | 2014 | 138 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 164 | 0.030 |
Why?
|
| Bone Density | 1 | 2013 | 145 | 0.020 |
Why?
|
| Sterilization | 1 | 2012 | 9 | 0.020 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 2011 | 14 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 157 | 0.020 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2013 | 196 | 0.020 |
Why?
|
| Horses | 1 | 2011 | 10 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2011 | 21 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 5 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 19 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 617 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 153 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 258 | 0.020 |
Why?
|
| Sutures | 1 | 2010 | 54 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 375 | 0.020 |
Why?
|
| Joint Capsule | 1 | 2010 | 60 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 180 | 0.020 |
Why?
|
| Swine | 1 | 2009 | 73 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2008 | 18 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 51 | 0.020 |
Why?
|
| Sheep | 1 | 2008 | 19 | 0.020 |
Why?
|
| Rupture | 1 | 2009 | 111 | 0.020 |
Why?
|
| Shoulder Injuries | 1 | 2010 | 145 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 2185 | 0.020 |
Why?
|
| Biopsy | 1 | 2008 | 201 | 0.020 |
Why?
|
| Arthrometry, Articular | 1 | 2007 | 13 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 597 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2007 | 84 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2010 | 316 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3540 | 0.010 |
Why?
|